BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND PSA AND Staging
11 results:

  • 1. Prostate cancer metastasis to the testis: an unexpected presentation of a solitary recurrence.
    McCann C; Doherty A; Flynn C; Mulholland C
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33653833
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Solitary prostatic cancer metastasis to the testis: A case report and lessons to learn.
    Ismail A; Elmansy H; Shahrour W; Prowse O; Kotb A
    Arch Ital Urol Androl; 2020 Jan; 91(4):265-266. PubMed ID: 31937094
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Painful testicular metastasis from prostate adenocarcinoma.
    Lee KA; Mayer E; Khoo V
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29212868
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer.
    Sapre N; Pedersen J; Hong MK; Harewood L; Peters J; Costello AJ; Hovens CM; Corcoran NM
    BJU Int; 2012 Dec; 110 Suppl 4():58-63. PubMed ID: 23194127
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
    Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
    Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Positron emission tomography (PET) in the urooncological evaluation of the small pelvis.
    Machtens S; Serth J; Meyer A; Kleinhorst C; Ommer KJ; Herbst U; Kieruij M; Boerner AR
    World J Urol; 2007 Aug; 25(4):341-9. PubMed ID: 17624533
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nuclear medicine studies of the prostate, testes, and bladder.
    Jana S; Blaufox MD
    Semin Nucl Med; 2006 Jan; 36(1):51-72. PubMed ID: 16356796
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Positron emission tomography (PET): application in urogenital system oncologic diseases].
    Lomeña F; Simó M; Setoain X; Pérez G
    Arch Esp Urol; 2001; 54(6):649-60. PubMed ID: 11512406
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Complete androgen blockade versus chemical castration in advanced prostatic cancer: analysis of an Italian multicentre study. Italian Leuprorelin Group.
    Bono AV; DiSilverio F; Robustelli della Cuna G; Benvenuti C; Brausi M; Ferrari P; Gibba A; Galli L
    Urol Int; 1998; 60 Suppl 1():18-24. PubMed ID: 9563140
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Nuclear medicine diagnosis and therapy in urology. Diagnosis of bone metastases].
    Hach A; Melchior SW; Andreas J; Piepenburg R; Voges GE
    Urologe A; 1993 Mar; 32(2):94-102. PubMed ID: 8475616
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.